本文字数：915，阅读时长大约1.5分钟 作者 | 第一财经 葛慧 6月1日，各大新能源汽车新势力晒出战报。 极氪、零跑、鸿蒙智行和理想以超过4万辆的数据站在头部。极氪科技5月销量46538辆，同比增长 15.2%，环比增长12.6%，连续三个月月销超4万辆。鸿蒙智行全系交付新车44454辆，再创新 高。两家公司均在月报中强调了高端市场的定位。 2025.06. 02 零跑汽车和理想汽车则是单品牌交付超过4万辆。 其中零跑汽车45607辆，已经连续三个月位居新势力单品牌第一。零跑在大众化新能源汽车市场保 持较为强劲增速。"零跑坚持核心技术全域自研，这让我们建立了成本可控、品质可控的技术优 势。"零跑汽车董事长朱江明表示。 站在3万辆阵营的只有小鹏，这已经是该品牌连续7个月交付站在3万辆上方。 理想汽车在5月交付了40856辆，环比增幅达到20.4%。5月29日，理想汽车管理层在一季度财报电 话会上表示，理想焕新版车型上新后，每周销量均超过1万辆。 3万辆以下阵营中，小米汽车本月仍然显示超28000辆，由于具体数字不详，难以判断销售环比增减 情况。 蔚来汽车在5月交付23231辆，同比增长13.1%。其中乐道汽 ...

关注 「电动车公社」 和我们一起重新思考汽车 5月的新能源汽车市场，可以用大盘稳健、局部震荡来形容 。 不变的是，市场销售态势依旧一片火热。在国补政策加持下，领头的比亚迪、吉利、奇瑞这三家也先后开启了限时优惠，其他品牌逐步跟进，把新能源的盘子 越做越大； 而出现变化的，则是具体到各家的销量排名，以及个别品牌1号的"考勤情况"。 相信各位小伙伴也看出来了，车企早就习惯了报喜不报忧：成绩好就发得早，不太理想就暂时缺席，下个月再重振旗鼓…… 因此，大部分汽车集团、乃至独立品牌，都没有形成在1号必发销量的习惯。 那么，1号发销量的品牌里，究竟表现如何？ 我们一起来看看这份5月份的交付量/销量成绩单吧~ 比亚迪5月乘用车销量376930台 5月，吉利汽车新能源销量138021台。其中，吉利银河品牌销量101845台，领克新能源家族销量17268台，极氪品牌交付18908台。 5月，比亚迪乘用车销量376930台。其中王朝+海洋348393台，方程豹12592台，腾势15806台，仰望汽车139台。 1、 1月 2月 3月 4月 5月 新能源累销超 -- 1230万辆 比亚迪汽车 王朝|海洋 348393 五月销售 同比 ...

3 、此前北大和复旦调查显示 "95 后 " 仅 50% 每周有性生活，这种需求的下滑一定程度上也在冲击伟哥类 药物市场。 核心提示： 1 、国产 " 伟哥 " 枸橼酸西地那非片正面临严重的市场滞销问题，白云山、科伦药业等多家企业销量下 滑、库存激增； 2 、国内获批西地那非类药物达 91 款，扬子江、齐鲁制药等企业涌入，价格战激烈（如齐鲁 " 千威 " 单片 价格低至 2.08 元），此外，原研药如辉瑞万艾可价格降幅超 50% ，凭借品牌优势挤压国产仿制药市场。 凤凰网财经《公司研究院》 ------------------------------------------------ 然而，随着市场竞争加剧、消费观念转变以及社会趋势的变化，这一行业正面临前所未有的挑战。 多家含有"枸橼酸西地那非片"的上市公司在一季度集团出现业绩失速，龙头企业白云山更是营收净利双 下滑、库存高企，曾经的"明星产品"如今陷入滞销困境。 01 国产"伟哥"，严重滞销 曾被誉为"国产伟哥"代名词的枸橼酸西地那非片（西地那非仿制药），正经历前所未有的市场寒冬。国 内多家龙头企业业绩集体承压，库存积压问题凸显。 在白云山2024年年报 ...

Core Viewpoint - Novo Nordisk has experienced a significant decline in stock price, dropping over 50% within a year, primarily due to misjudgments in demand forecasting and competition from Eli Lilly's Zepbound [1][4][5] Group 1: Company Performance - Novo Nordisk briefly became the highest-valued company in Europe in 2023, surpassing LVMH, due to the high demand for Ozempic and Wegovy [1] - The company faced a 19% year-on-year sales growth in Q1, which was below expectations, leading to a downward revision of its annual sales guidance [4] - The CEO was forced to resign amid concerns about the company's declining market share and competitive position [8] Group 2: Competitive Landscape - Eli Lilly's Zepbound has surpassed Wegovy in weekly prescriptions in the U.S., indicating a shift in market dynamics [6] - Eli Lilly's aggressive marketing strategies and faster resolution of supply shortages have allowed it to gain a competitive edge over Novo Nordisk [6][7] - Novo Nordisk's conservative approach to demand management, including limiting new prescriptions, has allowed competitors to capitalize on supply shortages [5][6] Group 3: Research and Development - Novo Nordisk has faced setbacks in its R&D pipeline, with disappointing results from its next-generation weight loss drug CagriSema [8] - In contrast, Eli Lilly has reported positive clinical trial data for two promising experimental drugs, including an attractive oral version [7][8] Group 4: Market Position - Despite challenges, Novo Nordisk remains a global leader in GLP-1 drug sales, serving nearly two-thirds of patients using these medications for diabetes and obesity [9] - Analysts project that the weight loss drug market could reach $150 billion this year, indicating significant growth potential [9]

Core Viewpoint - Wantaibio is experiencing a significant decline in performance, attributed mainly to a sharp drop in its vaccine business, marking the most severe downturn in its history since going public [2][3][4]. Financial Performance - In 2024, Wantaibio's revenue was 2.245 billion yuan, a year-on-year decrease of 59.25%, following a revenue of 5.511 billion yuan in 2023, which was down 50.73% [3]. - The net profit attributable to shareholders in 2024 was 106 million yuan, down 91.49%, the lowest since the company was listed; the net profit after excluding non-recurring gains and losses was -186 million yuan, a decline of 117.29% [3]. - For Q1 2025, the company reported approximately 400 million yuan in revenue, a year-on-year decrease of 46.76%, with a net profit of -52.78 million yuan, a significant drop of 141.98% compared to a profit of 126 million yuan in the same period last year [4]. Vaccine Business Decline - The vaccine segment's revenue plummeted over 80%, with 2024 vaccine revenue at 606 million yuan, down 84.69% from 4.111 billion yuan the previous year [5]. - The production volume of vaccines in 2024 was 10.59 million doses, a decrease of 64.66%, while sales volume was 9.0492 million doses, down 42.4% [5]. - The market for HPV vaccines is facing intense competition, particularly from Watson Biotech and Merck's nine-valent HPV vaccine, which has further pressured Wantaibio's market share [6][9]. Future Prospects - Wantaibio is heavily investing in the development of its nine-valent HPV vaccine, with total R&D expenditures reaching 283 million yuan in 2024, accounting for 12.65% of its revenue [7]. - The company has committed 590 million yuan to the second-phase expansion of the nine-valent HPV vaccine project, which is 47% of the total project cost [7]. - Despite the challenges, Wantaibio aims to leverage the nine-valent HPV vaccine as a flagship product while expanding its portfolio of high-value vaccines to meet market demands [7][8].

以下文章来源于晚点Auto ，作者晚点团队 晚点Auto . | 公司名称 | 裁员时间 | 涉及人数 | 裁员原因 | 涉及部门/地区 | 后续计划 | | --- | --- | --- | --- | --- | --- | | 大众 | 2030年前 | 计划裁员3.5万人, | 成本削减、竞争加剧、 | 绝大部分 | 推进成本削减; | | | | 已裁7000人 | 排放罚款等 | 位于德国 | 暂不关闭德国工厂 | | 奔驰 | 2024年2月 | 中国区15%员工 | 提高效率、优化流程 | 销售和 | 整合冗余职位; | | | | | | 汽车金融业务 | 继续业务整合 | | | | | | 工程部门; | 合并架构项目; | | 福特 | 2024年11月、 2025年5月 | 在欧洲裁员4000人 350个软件岗位 | 市场紧张、削减成本 | 车联网软件团队; | 开发低成本电动车; | | | | | | 欧洲团队 | 统一软件体验 | | 通用 | 2025年4月 | 底特律200人; 奥沙瓦750人; | 美国关税、贸易变化 | 底特律电动车厂 | 调整奥沙瓦工厂; 减少对美出 ...

Core Insights - The Chinese coffee market is experiencing rapid growth, with the industry size expected to double from 136.4 billion yuan in 2020 to 202.8 billion yuan in 2024 [4][8] - The rise in coffee consumption is driven by faster lifestyles and social media trends, with consumers increasingly seeking out aesthetically pleasing coffee experiences [4][8] - The market is characterized by diverse consumption scenarios, including chain coffee shops, independent cafes, fast food outlets, tea shops, convenience stores, and self-service coffee machines [8][10][12] Market Dynamics - Chain coffee brands dominate the market, accounting for over 60% of the total coffee shops in China, with the number of coffee shops expected to exceed 1 million by 2024 [10][15] - Major players like Luckin Coffee and Starbucks are expanding aggressively, leveraging digital marketing and loyalty programs to retain customers [10][17] - Independent and specialty coffee shops focus on unique experiences and high-quality offerings, but face challenges in scaling and maintaining profitability [10][25] Competitive Landscape - The competition in the coffee market is intense, with both international brands like Starbucks and local brands like Luckin Coffee vying for market share [15][17] - Luckin Coffee has positioned itself as a cost-effective option, while new entrants like Kudi Coffee are adopting aggressive expansion strategies [19][21] - The market is witnessing a high closure rate of coffee shops, with over 4.5 million stores disappearing in 2024, indicating a challenging environment for many brands [27] Future Trends - The coffee market is expected to continue evolving, with a focus on supply chain management and operational efficiency becoming critical for survival [28][29] - Downstream markets are emerging as new growth areas, but brands must adapt to different consumer preferences and behaviors in these regions [31] - Digitalization and multi-channel marketing are essential for brands to understand consumer needs and enhance the overall customer experience [33][35]

美国联邦住房金融局（FHFA）主管Bill Pulte：FICO批准涨价，需要竞争。 ...

当任天堂Switch 2即将登场之际，苹果悄然发动了一场针对游戏市场的"反击战"，试图在一个它从未真 正统治过的领域宣示主权。 市场认知的挑战依然存在 尽管新应用可能会让苹果产品在游戏方面更易于使用，并使游戏类别更加突出，但该软件的测试人员表 示，这可能不会改变玩家和高端游戏制作者的认知。 报道指出，苹果通常不被视为游戏巨头，许多开发者和玩家认为Mac与Windows电脑相比仍有很大不 足。该应用是计划在下一版iOS中推出的几项功能之一，将于9月向用户发布——大约与下一代iPhone 产品线同时推出。 iPhone作为全球使用最广泛的游戏设备之一，游戏类别自2008年以来一直是App Store的核心。近年来， 开发者已经添加了《生化危机》、《死亡搁浅》和《刺客信条》等高端游戏。 目前，苹果App Store约三分之二的收入来自游戏和应用内购买，包括代币、关卡和其他游戏内升级。 5月28日据媒体报道，苹果将在今年晚些时候在iPhone、iPad、Mac和Apple TV机顶盒上预装一款专门的 游戏应用程序。该软件将充当游戏启动器，并集中管理游戏内成就、排行榜、通讯和其他活动功能。 这款新应用将提供App St ...

Core Insights - Meituan's Q1 financial results exceeded market expectations, with revenue of 865.57 billion RMB, a year-on-year increase of 18.1%, and adjusted net profit of 109.5 billion RMB, up 46.2% [1] - The core local business operating profit margin rose to 21%, despite CEO Wang Xing's warning of a significant year-on-year decline in Q2 core local business profits [1][2] - The competitive landscape in China's food delivery market has intensified, with rivals like JD and Ele.me implementing aggressive promotional policies [1][2] Financial Performance - The core local business generated revenue of 643.25 billion RMB, a 17.8% increase, contributing 74.3% of total revenue, with operating profit reaching 135 billion RMB, up 39.1% [2] - Revenue from delivery, commission, and advertising within the core local business was 257.2 billion RMB, 240.5 billion RMB, and 118.62 billion RMB, reflecting growth rates of 22.1%, 20.1%, and 15.1% respectively [2] - Meituan plans to pay social insurance for full-time and stable part-time delivery riders, with an expected average of 3.36 million riders nationwide by 2024 [2] New Business Growth - New business revenue grew by 19.2% to 222 billion RMB, with operating losses narrowing by 17.5% to 23 billion RMB, improving the operating loss margin by 4.6 percentage points to 10.2% [3] - The improvement in new business performance is attributed to growth in grocery retail and progress in overseas operations [3] International Expansion - Meituan announced a $1 billion investment in Brazil over the next five years, marking its entry into the South American market [4] - CEO Wang Xing expressed confidence in becoming a leading player in overseas markets [4]